BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 22644094)

  • 21. Successful gene therapy in older Rpe65-deficient dogs following subretinal injection of an adeno-associated vector expressing RPE65.
    Annear MJ; Mowat FM; Bartoe JT; Querubin J; Azam SA; Basche M; Curran PG; Smith AJ; Bainbridge JW; Ali RR; Petersen-Jones SM
    Hum Gene Ther; 2013 Oct; 24(10):883-93. PubMed ID: 24028205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
    Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
    Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosis.
    Ku CA; Chiodo VA; Boye SL; Goldberg AF; Li T; Hauswirth WW; Ramamurthy V
    Hum Mol Genet; 2011 Dec; 20(23):4569-81. PubMed ID: 21880665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high prevalence of biallelic RPE65 mutations in Costa Rican children with Leber congenital amaurosis and early-onset retinal dystrophy.
    Glen WB; Peterseim MMW; Badilla R; Znoyko I; Bourg A; Wilson R; Hardiman G; Wolff D; Martinez J
    Ophthalmic Genet; 2019 Apr; 40(2):110-117. PubMed ID: 30870047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term preservation of cones and improvement in visual function following gene therapy in a mouse model of leber congenital amaurosis caused by guanylate cyclase-1 deficiency.
    Mihelec M; Pearson RA; Robbie SJ; Buch PK; Azam SA; Bainbridge JW; Smith AJ; Ali RR
    Hum Gene Ther; 2011 Oct; 22(10):1179-90. PubMed ID: 21671801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy.
    Pennesi ME; Weleber RG; Yang P; Whitebirch C; Thean B; Flotte TR; Humphries M; Chegarnov E; Beasley KN; Stout JT; Chulay JD
    Hum Gene Ther; 2018 Dec; 29(12):1428-1437. PubMed ID: 29869534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effect of gene therapy on Leber's congenital amaurosis.
    Bainbridge JW; Mehat MS; Sundaram V; Robbie SJ; Barker SE; Ripamonti C; Georgiadis A; Mowat FM; Beattie SG; Gardner PJ; Feathers KL; Luong VA; Yzer S; Balaggan K; Viswanathan A; de Ravel TJ; Casteels I; Holder GE; Tyler N; Fitzke FW; Weleber RG; Nardini M; Moore AT; Thompson DA; Petersen-Jones SM; Michaelides M; van den Born LI; Stockman A; Smith AJ; Rubin G; Ali RR
    N Engl J Med; 2015 May; 372(20):1887-97. PubMed ID: 25938638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of human gene therapy for RPE65-associated Leber's congenital amaurosis on visual function: a systematic review and meta-analysis.
    Wang X; Yu C; Tzekov RT; Zhu Y; Li W
    Orphanet J Rare Dis; 2020 Feb; 15(1):49. PubMed ID: 32059734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
    Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
    PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.
    Testa F; Maguire AM; Rossi S; Pierce EA; Melillo P; Marshall K; Banfi S; Surace EM; Sun J; Acerra C; Wright JF; Wellman J; High KA; Auricchio A; Bennett J; Simonelli F
    Ophthalmology; 2013 Jun; 120(6):1283-91. PubMed ID: 23474247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leber's Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations.
    Huang CH; Yang CM; Yang CH; Hou YC; Chen TC
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections.
    Malvasi M; Casillo L; Avogaro F; Abbouda A; Vingolo EM
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy reforms photoreceptor structure and restores vision in NPHP5-associated Leber congenital amaurosis.
    Aguirre GD; Cideciyan AV; Dufour VL; Ripolles-GarcĂ­a A; Sudharsan R; Swider M; Nikonov R; Iwabe S; Boye SL; Hauswirth WW; Jacobson SG; Beltran WA
    Mol Ther; 2021 Aug; 29(8):2456-2468. PubMed ID: 33781914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RPE65 Mutations in Two Japanese Families with Leber Congenital Amaurosis.
    Katagiri S; Hayashi T; Kondo M; Tsukitome H; Yoshitake K; Akahori M; Ikeo K; Tsuneoka H; Iwata T
    Ophthalmic Genet; 2016 Jun; 37(2):161-9. PubMed ID: 25495949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy: light is finally in the tunnel.
    Cao H; Molday RS; Hu J
    Protein Cell; 2011 Dec; 2(12):973-89. PubMed ID: 22231356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration.
    Choi EH; Suh S; Foik AT; Leinonen H; Newby GA; Gao XD; Banskota S; Hoang T; Du SW; Dong Z; Raguram A; Kohli S; Blackshaw S; Lyon DC; Liu DR; Palczewski K
    Nat Commun; 2022 Apr; 13(1):1830. PubMed ID: 35383196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel.
    Banin E; Bandah-Rozenfeld D; Obolensky A; Cideciyan AV; Aleman TS; Marks-Ohana D; Sela M; Boye S; Sumaroka A; Roman AJ; Schwartz SB; Hauswirth WW; Jacobson SG; Hemo I; Sharon D
    Hum Gene Ther; 2010 Dec; 21(12):1749-57. PubMed ID: 20604683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Potential for LCA5-Associated Leber Congenital Amaurosis.
    Uyhazi KE; Aravand P; Bell BA; Wei Z; Leo L; Serrano LW; Pearson DJ; Shpylchak I; Pham J; Vasireddy V; Bennett J; Aleman TS
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):30. PubMed ID: 32428231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress in gene therapy study of Leber congenital amaurosis].
    Pan SS; Zheng QX; Li WS; Pang JJ
    Zhonghua Yan Ke Za Zhi; 2011 Jan; 47(1):83-7. PubMed ID: 21418933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
    Hussain RM; Tran KD; Maguire AM; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.